Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solaraze 3 vs 6 Months for Actinic Keratosis
NCT00204542Phase 4Completed
- Sponsor
- University Hospital Tübingen
- Start
- Jun 2005
- Primary completion
- Mar 2009
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of diclofenac in actinic keratosis (AK), sponsored by University Hospital Tübingen. Started Jun 2005; status: completed.
02
Drugs
diclofenac
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on NCT00204542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00204542.